scholarly article | Q13442814 |
P2093 | author name string | Holmes D | |
Wong J | |||
Sullivan JL | |||
Luzuriaga K | |||
Panicali DL | |||
Hereema A | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 433-443 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | HIV-1-specific cytotoxic T lymphocyte responses in the first year of life | |
P478 | volume | 154 |
Q24620746 | A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children |
Q38258081 | Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation |
Q35020912 | Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection |
Q35149075 | Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children |
Q91843704 | Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV |
Q35574412 | Defective antigen-presenting cell function in human neonates. |
Q37271461 | Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment |
Q33805975 | Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. |
Q35664125 | Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection |
Q33639399 | Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants |
Q37350178 | Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. |
Q36377103 | Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants |
Q33808891 | Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses |
Q35887052 | Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease |
Q39685522 | Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load |
Q36404594 | Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children |
Q33936741 | HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission |
Q35875709 | Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease |
Q36315692 | Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants |
Q37386643 | Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers |
Q34033051 | Immunity to HIV in Early Life |
Q34426299 | Immunity to cytomegalovirus in early life. |
Q30245481 | Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity |
Q58549248 | In utero priming of highly functional effector T cell responses to human malaria |
Q42214247 | In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth. |
Q34354961 | Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. |
Q33843438 | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants |
Q41478363 | Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya. |
Q35019349 | Mature CD8(+) T lymphocyte response to viral infection during fetal life |
Q93197879 | Mechanisms of Fetal T Cell Tolerance and Immune Regulation |
Q34741864 | Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity |
Q34359350 | Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines |
Q38773102 | Paediatric HIV infection: the potential for cure |
Q37243687 | Paediatric non-progression following grandmother-to-child HIV transmission |
Q54219253 | Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia. |
Q33558599 | Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate |
Q33533351 | Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants |
Q41923263 | Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape. |
Q37294337 | Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life |
Q36164091 | T cell-mediated immune responses in human newborns: ready to learn? |
Q38245181 | The immune tolerant phase of chronic HBV infection: new perspectives on an old concept |
Q38037339 | The impact of differential antiviral immunity in children and adults |
Q35591075 | The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression |
Q35232071 | Timing of lymphocyte activation in neonates infected with human immunodeficiency virus |
Q39419957 | Tolerance and immunity to pathogens in early life: insights from HBV infection. |
Q35311846 | Trained immunity in newborn infants of HBV-infected mothers |
Q35227609 | Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus |
Q33987347 | Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection |
Q35947967 | Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding |
Q37086886 | Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection |